NewEdge Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

NewEdge Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50	Closed	-$1	–	4361
2022 Q4	$1	Buy	+50	New	+$692	﹤0.01%	4072
2018 Q4	–	Sell	-1,340	Closed	-$44K	–	741
2018 Q3	$44K	Buy	+1,340	New	+$34.4K	﹤0.01%	649

NewEdge Advisors's AVEO Position: Q1 2023 in Review

NewEdge Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 50 shares — an estimated $1 sold.

NewEdge Advisors first reported a position in AVEO in Q3 2018 and held it in 2 quarters. The position peaked at $44K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

NewEdge Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 50 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.
NewEdge Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
NewEdge Advisors's AVEO Pharmaceuticals, Inc. position peaked at $44K in Q3 2018.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.